Bile-pancreaitic juice replacement not cholinergic- and cholecystokinin-receptor blockade reverses acinar cell hyperstimulation after bile-pancreatic duct ligation

American Journal of Surgery

Volumn 171, Issue 1, 1996, Pages 207-211

  Samuel, Isaac ^a   Joehl, Raymond J ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATROPINE; CHOLECYSTOKININ RECEPTOR; CHOLECYSTOKININ RECEPTOR BLOCKING AGENT; CHOLINERGIC RECEPTOR; DEVAZEPIDE;

ACINAR CELL; ACUTE PANCREATITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BILE; CONFERENCE PAPER; CONTROLLED STUDY; INTESTINE ABSORPTION; MALE; NONHUMAN; PANCREAS DUCT LIGATION; PANCREAS JUICE; PRIORITY JOURNAL; RAT;

AMYLASES; ANIMALS; ATROPINE; BENZODIAZEPINONES; BILE; BILE DUCTS; CHOLINERGIC ANTAGONISTS; DEVAZEPIDE; LIGATION; PANCREAS; PANCREATIC DUCTS; PANCREATIC JUICE; PANCREATITIS; RATS; RECEPTORS, CHOLECYSTOKININ;

EID: 0030032217     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9610(99)80101-9     Document Type: Article

References (13)

1. Samuel I, Toriumi Y, Wilcockson DP, et al. Bile and pancreatic juice replacement ameliorates early ligation-induced acute pancreatitis in rats. Am J Surg. 1995;169:391-399.
2. Toriumi Y, Samuel I, Wilcockson DP, et al. Octreotide and cholecystokinin antagonist reduce edema in obstruction-induced acute pancreatitis. J Lab Clin Med. 1993;122:450-454.
3. Toriumi Y, Samuel I, Wilcockson DP, et al. Atropine augments beneficial effects of octreotide and L-364,718 in obstruction-induced acute pancreatitis. Pancreas. 1992;7:761. Abstract.
4. Nakamura R, Miyasaka K, Funakoshi A, Kitani K. Interactions between bile and pancreatic juice diversions on cholecystokinin release and pancreas in conscious rats. Proc Soc Exp Biol Med. 1989;192: 182-186.
5. Chey WY. Regulation of pancreatic exocrine secretion. Int J Pancreatol. 1991;9:7-20.
6. Cameron JL, Mehigan D, Zuidema GD. Evaluation of atropine in acute pancreatitis. Surg Gynecol Obstet. 1979;148:206-208.
7. Owyang C, Louie DS, Tatum D. Feedback regulation of pancreatic enzyme secretion - suppression of cholecystokinin release by trypsin. J Clin Invest. 1986;77:2042-2047.
8. Boyd EJS, Gumming JGR, Cushieri A, Wormsley KG. Aspects of feedback control of pancreatic secretion in man. Ital J Gastroenterol. 1985;17:18-22.
9. Ihse I, Lilja P, Lundquist I. Feedback regulation of pancreatic enzyme secretion by intestinal trypsin in man. Digestion. 1977;15:303-308.
10. Liener IE, Goodale RL, Deshmukh A, et al. Effect: of a trypsin inhibitor from soybeans (Bowman-Birk) on the secretory activity of the human pancreas. Gastroenterology. 1988;94:419-427.
11. Burton FR, Burton MS, Garvin PJ, Joshi SN. Enteral pancreatic enzyme feedback inhibition of exocrine secretion of the human transplanted pancreas. Transplantation. 1992;54:988-991.
12. Slaff JI, Wolfe MM, Toskes PP. Elevated fasting cholecystokinin levels in pancreatic exocrine impairment: evidence to support feedback regulation. J Lab Clin Med. 1985;105:282-285.
13. Adler G, Beglinger C, Braun U, et al. Interaction of the cholinergic system and cholecystokinin in the regulation of endogenous and exogenous stimulation of pancreatic secretion in humans. Gastroenterology. 1991;100:537-543.